
Gerd Heilemann, PhD
Department of Radiation Oncology
Position: Research Associate (Postdoc)
ORCID: 0000-0002-7461-3956
T +43 1 40400 72710
Keywords
Artificial Intelligence; Medical Physics; Radiation Oncology
Research group(s)
- Medical Radiation Research
Head: Dietmar Georg
Research Area: The vision of our group is the optimization of the treatment outcome of radiation oncology, alone or in combination with established chemotherapy or novel targeted strategies of drug treatment, with conventional photon or innovative ion-beams.
Members:
Selected publications
- Heilemann, G. et al., 2018. Retina dose as a predictor for visual acuity loss in 106 Ru eye plaque brachytherapy of uveal melanomas. Radiotherapy and Oncology, 127(3), pp.379-384. Available at: http://dx.doi.org/10.1016/j.radonc.2017.11.010.
- Heilemann, G. et al., 2017. Treatment plan optimization and robustness of 106 Ru eye plaque brachytherapy using a novel software tool. Radiotherapy and Oncology, 123(1), pp.119-124. Available at: http://dx.doi.org/10.1016/j.radonc.2017.01.010.
- Heilemann, G. et al., 2015. Multidimensional dosimetry of 106Ru eye plaques using EBT3 films and its impact on treatment planning. Medical Physics, 42(10), pp.5798-5808. Available at: http://dx.doi.org/10.1118/1.4929564.
- Heilemann, G., Poppe, B. & Laub, W., 2013. On the sensitivity of common gamma-index evaluation methods to MLC misalignments in Rapidarc quality assurance. Medical Physics, 40(3), p.031702. Available at: http://dx.doi.org/10.1118/1.4789580.